相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hepatic and Intestinal Drug Transporters: Prediction of Pharmacokinetic Effects Caused by Drug-Drug Interactions and Genetic Polymorphisms
Kenta Yoshida et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 53, 2013 (2013)
Absolute abundance and function of intestinal drug transporters: a prerequisite for fully mechanistic in vitro-in vivo extrapolation of oral drug absorption
M. D. Harwood et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2013)
ITC Recommendations for Transporter Kinetic Parameter Estimation and Translational Modeling of Transport-Mediated PK and DDIs in Humans
M. J. Zamek-Gliszczynski et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Model-based approaches to predict drug-drug interactions associated with hepatic uptake transporters: preclinical, clinical and beyond
Hugh A. Barton et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2013)
Cyclosporine Inhibition of Hepatic and Intestinal CYP3A4, Uptake and Efflux Transporters: Application of PBPK Modeling in the Assessment of Drug-Drug Interaction Potential
Michael Gertz et al.
PHARMACEUTICAL RESEARCH (2013)
Mechanistic Modeling to Predict the Transporter- and Enzyme-Mediated Drug-Drug Interactions of Repaglinide
Manthena V. S. Varma et al.
PHARMACEUTICAL RESEARCH (2013)
Predicting drug-drug interactions: application of physiologically based pharmacokinetic models under a systems biology approach
Karen Rowland Yeo et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2013)
Quantitative Prediction of Repaglinide-Rifampicin Complex Drug Interactions Using Dynamic and Static Mechanistic Models: Delineating Differential CYP3A4 Induction and OATP1B1 Inhibition Potential of Rifampicin
Manthena V. S. Varma et al.
DRUG METABOLISM AND DISPOSITION (2013)
Understanding the Critical Disposition Pathways of Statins to Assess Drug-Drug Interaction Risk During Drug Development: It's Not Just About OATP1B1
R. Elsby et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Physiologically Based Pharmacokinetics Joined With In Vitro-In Vivo Extrapolation of ADME: A Marriage Under the Arch of Systems Pharmacology
A. Rostami-Hodjegan
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Functional Pleiotropy of Organic Anion Transporting Polypeptide OATP2B1 Due to Multiple Binding Sites
Yoshiyuki Shirasaka et al.
DRUG METABOLISM AND PHARMACOKINETICS (2012)
Physiologically Based Modeling of Pravastatin Transporter-Mediated Hepatobiliary Disposition and Drug-Drug Interactions
Manthena V. S. Varma et al.
PHARMACEUTICAL RESEARCH (2012)
Mechanistic Pharmacokinetic Modeling for the Prediction of Transporter-Mediated Disposition in Humans from Sandwich Culture Human Hepatocyte Data
Hannah M. Jones et al.
DRUG METABOLISM AND DISPOSITION (2012)
Simultaneous Assessment of Uptake and Metabolism in Rat Hepatocytes: A Comprehensive Mechanistic Model
Karelle Menochet et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Interplay of Metabolism and Transport in Determining Oral Drug Absorption and Gut Wall Metabolism: A Simulation Assessment Using the “Advanced Dissolution, Absorption, Metabolism (ADAM)” Model
A. S. Darwich et al.
CURRENT DRUG METABOLISM (2011)
Culture Period-Dependent Changes in the Uptake of Transporter Substrates in Sandwich-Cultured Rat and Human Hepatocytes
Naoki Kotani et al.
DRUG METABOLISM AND DISPOSITION (2011)
Clinical Importance of OATP1B1 and OATP1B3 in Drug-Drug Interactions
Yoshihisa Shitara
DRUG METABOLISM AND PHARMACOKINETICS (2011)
Use of Transporter Knockdown Caco-2 Cells to Investigate the In Vitro Efflux of Statin Drugs
Jibin Li et al.
DRUG METABOLISM AND DISPOSITION (2011)
The International Transporter Consortium: A Collaborative Group of Scientists From Academia, Industry, and the FDA
S-M Huang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Cyclosporine A, but Not Tacrolimus, Shows Relevant Inhibition of Organic Anion-Transporting Protein 1B1-Mediated Transport of Atorvastatin
Rune Amundsen et al.
DRUG METABOLISM AND DISPOSITION (2010)
Physiologically based mechanistic modelling to predict complex drug-drug interactions involving simultaneous competitive and time-dependent enzyme inhibition by parent compound and its metabolite in both liver and gut-The effect of diltiazem on the time-course of exposure to triazolam
Karen Rowland Yeo et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Effect of a Single Gemfibrozil Dose on the Pharmacokinetics of Rosuvastatin in Bile and Plasma in Healthy Volunteers
Ebba Bergman et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
A Valid Equation for the Well-Stirred Perfusion Limited Physiologically Based Pharmacokinetic Model that Consistently Accounts for the Blood-Tissue Drug Distribution in the Organ and the Corresponding Valid Equation for the Steady State Volume of Distribution
Leonid M. Berezhkovskiy
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Application of physiologically based pharmacokinetic modeling and clearance concept to drugs showing transporter-mediated distribution and clearance in humans
Takao Watanabe et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2010)
Influence of Purple Grape Juice in Cyclosporine Bioavailability
Vera L. Oliveira-Freitas et al.
JOURNAL OF RENAL NUTRITION (2010)
Membrane transporters in drug development
Kathleen M. Giacomini et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Population-Based Mechanistic Prediction of Oral Drug Absorption
Masoud Jamei et al.
AAPS JOURNAL (2009)
No significant effect of ABCB1 haplotypes on the pharmacokinetics of fluvastatin, pravastatin, lovastatin, and rosuvastatin
Jenni E. Keskitalo et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Towards a Quantitative Framework for the Prediction of DDIs Arising from Cytochrome P450 Induction
L. M. Almond et al.
CURRENT DRUG METABOLISM (2009)
Use of Sandwich-Cultured Human Hepatocytes to Predict Biliary Clearance of Angiotensin II Receptor Blockers and HMG-CoA Reductase Inhibitors
Koji Abe et al.
DRUG METABOLISM AND DISPOSITION (2009)
Enterohepatic Disposition of Rosuvastatin in Pigs and the Impact of Concomitant Dosing with Cyclosporine and Gemfibrozil
Ebba Bergman et al.
DRUG METABOLISM AND DISPOSITION (2009)
The Simcyp® Population-based ADME Simulator
Masoud Jamei et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)
Prediction of pharmacokinetic profile of valsartan in human based on in vitro uptake transport data
Agnes Poirier et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2009)
Physiologically Based Pharmacokinetic Modeling to Predict Transporter-Mediated Clearance and Distribution of Pravastatin in Humans
Takao Watanabe et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Mechanistic Modeling of Hepatic Transport from Cells to Whole Body: Application to Napsagatran and Fexofenadine
Agnes Poirier et al.
MOLECULAR PHARMACEUTICS (2009)
Assessing drug distribution in tissues expressing P-glycoprotein through physiologically based pharmacokinetic modeling: model structure and parameters determination
Frederique Fenneteau et al.
THEORETICAL BIOLOGY AND MEDICAL MODELLING (2009)
Prediction of the pharmacokinetics of atorvastatin, cerivastatin, and indomethacin using kinetic models applied to isolated rat hepatocytes
Stuart W. Paine et al.
DRUG METABOLISM AND DISPOSITION (2008)
Covariation of Human Microsomal Protein Per Gram of Liver with Age: Absence of Influence of Operator and Sample Storage May Justify Interlaboratory Data Pooling
Z. E. Barter et al.
DRUG METABOLISM AND DISPOSITION (2008)
Design, Data Analysis, and Simulation of in Vitro Drug Transport Kinetic Experiments Using a Mechanistic in Vitro Model
Agnes Poirier et al.
DRUG METABOLISM AND DISPOSITION (2008)
Involvement of multiple transporters in the hepatobiliary transport of rosuvastatin
Satoshi Kitamura et al.
DRUG METABOLISM AND DISPOSITION (2008)
(3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(methyl(1-methyl-1H-1,2,4-triazo1-5-yl)amino)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid (BMS-644950):: A rationally designed orally efficacious 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitor with reduced myotoxicity potential
Saleem Ahmad et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Different effects of SLCO1B1 polymorphism on the pharmacokinetics of atorvastatin and rosuvastatin
M. K. Pasanen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Kinetic determinants of hepatic clearance: Plasma protein binding and hepatic uptake
M. Baker et al.
XENOBIOTICA (2007)
Role of OATP transporters in the disposition of drugs
Mikko Niemi
PHARMACOGENOMICS (2007)
Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data:: Reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver
Zoe E. Barter et al.
CURRENT DRUG METABOLISM (2007)
Biliary secretion of rosuvastatin and bile acids in humans during the absorption phase
Ebba Bergman et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Physiologically based pharmacokinetic modelling 2: Predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions
Trudy Rodgers et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
ATP-dependent transport of rosuvastatin in membrane vesicles expressing breast cancer resistance protein
LY Huang et al.
DRUG METABOLISM AND DISPOSITION (2006)
Drug and bile acid transporters in rosuvastatin hepatic uptake: Function, expression, and pharmacogenetics
Richard H. Ho et al.
GASTROENTEROLOGY (2006)
Changes in liver volume from birth to adulthood: A meta-analysis
TN Johnson et al.
LIVER TRANSPLANTATION (2005)
Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment
E Lee et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Tissue distribution of basic drugs:: Accounting for enantiomeric, compound and regional differences amongst β-blocking drugs in rat
T Rodgers et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Physiologically based pharmacokinetic modeling 1: Predicting the tissue distribution of moderate-to-strong bases
T Rodgers et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporine
SG Simonson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Association between the number of coadministered P-glycoprotein inhibitors and serum digoxin levels in patients on therapeutic drug monitoring
Gunilla Englund et al.
BMC MEDICINE (2004)
The effect of gemfibrozil on the pharmacokinetics of rosuvastatin
DW Schneck et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Absolute oral bioavailability of rosuvastatin in healthy white adult male volunteers
PD Martin et al.
CLINICAL THERAPEUTICS (2003)
A double-blind, randomized, incomplete crossover trial to assess the dose proportionality of rosuvastatin in healthy volunteers
PD Martin et al.
CLINICAL THERAPEUTICS (2003)
Human jejunal permeability of cyclosporin A: Influence of surfactants on P-glycoprotein efflux in Caco-2 cells
YY Chiu et al.
PHARMACEUTICAL RESEARCH (2003)
Effect of itraconazole on the pharmacokinetics of rosuvastatin
KJ Cooper et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Metabolism, excretion, and pharmacokinetics of rosuvastatin in healthy adult male volunteers
PD Martin et al.
CLINICAL THERAPEUTICS (2003)
Effects of fibrates on metabolism of statins in human hepatocytes
T Prueksaritanont et al.
DRUG METABOLISM AND DISPOSITION (2002)
Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteers
PD Martin et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2002)
The effect of fluconazole on the pharmacokinetics of rosuvastatin
KJ Cooper et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Prediction of pharmacokinetics prior to in vivo studies.: II.: Generic physiologically based pharmacokinetic models of drug disposition
P Poulin et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2002)
Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution
P Poulin et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2002)
Gender-dependent racial difference in disposition of cyclosporine among healthy African American and white volunteers
DI Min et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
分享论文
